Wednesday, 19 September 2018

The European & Developing Countries Clinical Trials Partnership (EDCTP) Call For Proposals

EDCTP-TDR Clinical Research and Development Fellowships

Open for applications: 31 October 2014

Deadline for applications: 30 January 2015, 16:00 (GMT)


Researchers from low and middle-income countries (LMICs) who are involved in clinical research projects have limited opportunities to acquire experience and develop skills for conducting clinical trials outside of an academic or public sector setting. EDCTP and Training in Tropical Diseases (TDR) have decided to jointly implement a fellowship scheme that will support researchers to obtain these skills, while ensuring synergies between researchers and clinical staff, pharmaceutical companies, product development partnerships (PDPs) and research institutions. This partnership will have a leverage effect on the number of individuals trained, resulting in an increased impact on research and development capacity in LMICs.


The purpose of this Joint Call for Proposals is to support researchers and key members of clinical trial research teams from LMICs to acquire specialist skills in clinical research and development through placements in pharmaceutical companies and PDPs. The scheme targets junior to mid-career researchers or clinical staff (clinicians, pharmacists, medical statisticians, data managers, other health researchers) who are employed by a legal entity in LMICs where they are currently working on activities in the scope of EDCTP or TDR. The EDCTP-TDR partnership includes a joint evaluation and selection process of applications submitted to this Call. However, grant awarding and budget management are managed separately by each organisation1. TDR will fund fellows employed by a research institution in any LMIC to be placed in pharmaceutical companies and PDPs either in or outside Europe to train and develop new research skills on infectious diseases including HIV/AIDS, TB, malaria, Ebola and NIDs2. EDCTP will fund fellows employed by a sub-Saharan African legal entity to be placed in European-based pharmaceutical companies to train and develop new research skills of relevance to PRDs3.

Fellows can only be funded once under this grant scheme. Grants awarded are not transferrable from one individual to another. Placements are for a minimum period of 6 months up to a maximum period of 24 months. Fellows must be committed to return to their home organisation for a minimum of two years after completion of the fellowship. Fellows should be able to demonstrate how the experience gained during the training programme will be applied upon return to their home organisation.
Download Full PDF Document
Download Guide for Applicants

Diagnostic Tools for Poverty Related Diseases

Type of Action Research and Innovation Action (RIA)

Call Budget 15M Euros
Expected number of grants 4-8

Stage 1: Open for letters of intent 2 December 2014
Deadline for letters of intent 2 March 2015, 16:00 (GMT); 17:00 (CET)

Stage 2: open for full applications 30 April 2015
Deadline for full applications 7 July 2015

Status Open


Disease diagnosis in sub-Saharan Africa is highly challenging, as the population is predominantly rural and the health care systems often have limited resources. Early and rapid diagnosis of poverty-related diseases (PRDs)1 offers the best opportunity for patients to receive timely and appropriate treatment, but adequate diagnostic tools are not readily available because of a lack of drive to develop and deploy them in disease-endemic countries. Therefore, there is a clear need for the development and uptake of rapid, accurate, cost-effective, scalable and field-friendly diagnostic tools.


The purpose of this Call for Proposals is to provide funding to projects focusing on validation of the clinical performance and/or implementation of new or improved diagnostic tools and technologies for detection of any of the PRDs, including as co-infections. These tools and technologies should improve the performance of diagnosis, prediction, monitoring, intervention or assessment of therapeutic response, with a significant impact on clinical decision and health outcomes. Applications should focus on late stage development (e.g. evaluation and/or demonstration phase trials) or implementation studies in sub-Saharan Africa. Applications should further provide detailed plans for World Health Organisation (WHO) endorsement and/or implementation of the diagnostic tools and technologies upon successful completion ofthe project. Proposals focused entirely on early-stage, laboratory-based studies using biobanked samples are outside the scope of this call. Priority will be given to point-of-care diagnostics for use in resource-limited settings.

EDCTP considers that proposals of between 36 and 60 months duration would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals for activities of a different duration.

Download Full PDF Document

Download Guide for Applicants

Select UVRI Video to watch